A potential role for the gut microbiome in substance use disorders

2019/04/13 by Katherine R. Meckel, Katherine Meckel, Drew D. Kiraly · 148 citations
Biochemistry, Genetics and Molecular Biology · Medicine · Neuroscience · #Addiction #Bioinformatics #Biology #Diet and metabolism studies #Drug #Dysbiosis #Gut flora #Gut microbiome #Gut microbiota and health #Human Microbiome Project #Human microbiome #Immunology #Mechanism (biology) #Medicine #Microbiome #Psychiatry #Substance abuse #Substance use #Tryptophan and brain disorders

paper · open access · doi:10.1007/s00213-019-05232-0

published in Psychopharmacology 236(5), 1513-1530 (Springer Science+Business Media)

openalex publication_date 2019/04/13 · openalex created_date 2025/10/10 · openalex updated_date 2026/07/29

Citations

• Assessment of psychotropic-like properties of a probiotic formulation (Lactobacillus helveticusR0052 andBifidobacterium longumR0175) in rats and human subjects
• Ingestion of Lactobacillus strain regulates emotional behavior and central GABA receptor expression in a mouse via the vagus nerve

Cited by

• The rising crisis of illicit fentanyl use, overdose, and potential therapeutic strategies. [europepmc]
• Metabolomics in Psychiatric Disorders: What We Learn from Animal Models. [europepmc]
• Sex-dependent associations between addiction-related behaviors and the microbiome in outbred rats. [europepmc]
• Methamphetamine and Cannabis: A Tale of Two Drugs and their Effects on HIV, Brain, and Behavior. [europepmc]
• Sensitivity to Morphine Reward Associates With Gut Dysbiosis in Rats With Morphine-Induced Conditioned Place Preference. [europepmc]
• Dysbiosis in the Dead: Human Postmortem Microbiome Beta-Dispersion as an Indicator of Manner and Cause of Death. [europepmc]
• Human Gut Microbiota and Mental Health: Advancements and Challenges in Microbe-Based Therapeutic Interventions. [europepmc]
• Microbiome Profiling Reveals Gut Dysbiosis in the Metabotropic Glutamate Receptor 5 Knockout Mouse Model of Schizophrenia. [europepmc]
• Effects of Extended Postmortem Interval on Microbial Communities in Organs of the Human Cadaver. [europepmc]
• Evidence for Modulation of Substance Use Disorders by the Gut Microbiome: Hidden in Plain Sight. [europepmc]
• Contributions of neuroimmune and gut-brain signaling to vulnerability of developing substance use disorders. [europepmc]
• Alterations in microbiome composition and metabolic byproducts drive behavioral and transcriptional responses to morphine. [europepmc]
• Schizophrenia, the gut microbiota, and new opportunities from optogenetic manipulations of the gut-brain axis. [europepmc]
• Bacteroides uniformis CECT 7771 Modulates the Brain Reward Response to Reduce Binge Eating and Anxiety-Like Behavior in Rat. [europepmc]
• The Gut Microbiome and Substance Use Disorder. [europepmc]
• Drugs and Bugs: The Gut-Brain Axis and Substance Use Disorders. [europepmc]
• The effects of probiotics administration on the gut microbiome in adolescents with anorexia nervosa-A study protocol for a longitudinal, double-blind, randomized, placebo-controlled trial. [europepmc]
• Opioid Use, Gut Dysbiosis, Inflammation, and the Nervous System. [europepmc]
• Could Alcohol Abuse and Dependence on Junk Foods Inducing Obesity and/or Illicit Drug Use Represent Danger to Liver in Young People with Altered Psychological/Relational Spheres or Emotional Problems? [europepmc]
• Gut colonization by Proteobacteria alters host metabolism and modulates cocaine neurobehavioral responses. [europepmc]
• Seeking the Psilocybiome: Psychedelics meet the microbiota-gut-brain axis. [europepmc]
• The Microbiome-Gut-Brain axis regulates social cognition & craving in young binge drinkers. [europepmc]
• Cross-talks between gut microbiota and tobacco smoking: a two-sample Mendelian randomization study. [europepmc]
• Microbial short-chain fatty acids regulate drug seeking and transcriptional control in a model of cocaine seeking. [europepmc]
• The impact of aging-induced gut microbiome dysbiosis on dendritic cells and lung diseases. [europepmc]